Corconsult Rx: Evidence-based Medicine And Pharmacy

On this episode, we review several drugs that have been approved by the FDA over the last year. The list of drugs that we review are below: Brexafemme (ibrexafungerp) Wegovy (semaglutide) Aducanumab (Aduhelm) Kerendia (finerenone) Zimhi (naloxone hydrochloride) Tyrvaya (varenicline) Nasal Spray PreHevbrio (hepatitis B vaccine (recombinant) Verquvo (vericiguat) Cabenuva (cabotegravir and rilpivirine) Extended-Release Injectable Evkeeza (evinacumab-dgnb) Injection Azstarys (dexmethylphenidate and serdexmethylphenidate) Lybalvi (olanzapine and samidorphan)  Tezspire (tezepelumab-ekko) Injection Leqvio (inclisiran) Injection Quviviq (daridorexant) Ruxolitinib (Opzelura) cream Tralokinumab (Adbry) Abrocitinib (Cibinqo) Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We continue to partner with freeCE to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. To earn credit for